Products for Research Use Only
RegisterLogin

BC-DXI-843

CAT: 0013-GTR19166224-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19166224-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BC-DXI-843 is a small molecule inhibitor targeting the oncogenic splice variant AIMP2-DX2. It shows potential for developing novel lung cancer therapeutics, with research applications in both in vitro cell-based assays and in vivo xenograft models to study its anti-tumor effects.
CAS Number
2421117-98-6
Product Name Alternative
A549, AIMP2-DX2, BC DXI 843, BC-DXI 843, BCDXI843, BC-DXI843, BC-DXI-843, cancer, Inhibitor, inhibit, lung
Purity
98.85% (May vary between batches)
Solubility
DMSO:245 mg/mL (448.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.15 mM)
Smiles
COc1ccc (cc1) -c1csc (NC (=O) [C@H] (Cc2c[nH]c3ccccc23) NS (=O) (=O) c2ccc (C) cc2) n1
Molecular Formula
C28H26N4O4S2
Molecular Weight
546.66
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19240116BC-DXI-32982
GTR19205720-01GSK-843
GTR19244392-01GSK-843
GTR19154278-01GSK'843
GTR19276221-01CRBN ligand-843
GTR19156075-01BC-1258
GTR19030287BC 197
GTR19237917-01BC-1293
GTR19234221-01BC-1901S
GTR19218859-01BC-05

Alternative Products

CatalogName
MBS3611933-01BC-DXI-843
T11474GSK-843
HY-109125SPK-843
A18526-1GSK-843 1mg
315594FAK (Ab-843)
A18526-100GSK-843 100mg

Popular Products